\-\ Texto\\:\\ \ \(0\)\
\-\ \\&\\#61548\\;\\ lab\\ eval\\:\ \(0\)\
\-\ \\&\\#8211\\;\\ free\\ t4\\ \\=\\ 5\\.33\\ \\(h\\)\ \(0\)\
\-\ \\&\\#8211\\;\\ tsh\\ \\=\\ 0\\.00\\ \\(l\\)\ \(0\)\
\-\ \\&\\#8211\\;\\ thyroid\\ peroxidase\\ \\=\\ 10\\ iu\\/ml\ \(0\)\
\-\ treatment\ \(1387\)\
\-\ \\&\\#61548\\;\\ medical\\ \\(anti\\-thyroid\\ drugs\\)\ \(0\)\
\-\ \\&\\#61548\\;\\ surgical\ \(0\)\
\-\ \\&\\#61548\\;\\ i131\\ ablation\\:\\ \\ safe\\,\\ effective\\,\\ economical\\.\\ \\ complications\\ include\\ hypothyroidism\\ \\(typical\\)\\,\\ radiation\\ thyroiditis\\,\\ rare\\ thyroid\\ storm\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ i131\\ dose\\:\ \(0\)\
\-\ \\&\\#8211\\;\\ usual\\ dose\\ varies\\ depending\\ on\\ treating\\ nuclear\\ medicine\\ physician\\'s\\ preference\\ \\(i\\.e\\.\\ standard\\ dose\\ versus\\ dosage\\ determination\\ based\\ on\\ raiu\\ and\\ estimated\\ gland\\ size\\)\ \(0\)\
\-\ findings\ \(1459\)\
\-\ \\&\\#61548\\;\\ 24\\ hr\\ raiu\\ demonstrated\\ elevated\\ uptake\\ of\\ 37\\.5\\%\\.\\ \\ normal\\ is\\ 8\\-30\\%\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ pertechnetate\\ evaluation\\ shows\\ a\\ moderately\\ enlarged\\ gland\\ with\\ homogeneous\\ trapping\\ of\\ radiotracer\\.\\ \\ no\\ focal\\ increased\\ or\\ decreased\\ accumulation\\.\ \(0\)\
\-\ procedure\ \(335\)\
\-\ \\&\\#61548\\;\\ radiotracers\\:\ \(0\)\
\-\ \\&\\#8211\\;\\ i131\\:\\ t1\\/2\\ \\=\\ 8\\ days\\,\\ b\\-\\ decay\\,\\ principal\\ photon\\ energy\\:\\ 364\\ kev\\,\\ produced\\ in\\ a\\ reactor\\.\ \(0\)\
\-\ \\&\\#8211\\;\\ pertechnetate\\:\\ t1\\/2\\ \\=\\ 6hr\\,\\ decay\\ by\\ isomeric\\ transition\\,\\ principal\\ photon\\ energy\\:\\ 140\\ kev\\,\\ produced\\ in\\ a\\ generator\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ 5\\ uci\\ of\\ i131\\ is\\ administered\\ po\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ will\\ concentrate\\ in\\ gland\\ and\\ the\\ functional\\ status\\ can\\ be\\ determined\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ 24\\ hrs\\ later\\,\\ concentration\\ in\\ thyroid\\ gland\\ is\\ determined\\ using\\ a\\ single\\ crystal\\ counting\\ probe\\ and\\ compared\\ to\\ an\\ identical\\ \\&\\#8220\\;standard\\&\\#8221\\;\\ dose\\ in\\ a\\ neck\\ phantom\\.\ \(2\)\
\-\ \\&\\#61548\\;\\ correction\\ for\\ background\\ activity\\ is\\ made\\ and\\ the\\ following\\ equation\\ is\\ used\\ to\\ determin\\ \\%\\ thyroid\\ uptake\\:\ \(0\)\
\-\ \\&\\#61548\\;\\ \\%\\ uptake\\=counts\\ in\\ neck\\-counts\\ in\\ thigh\\ \\ x\\ 100\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ divided\\ by\\ counts\\ in\\ standard\ \(0\)\
\-\ \\&\\#61548\\;\\ to\\ obtain\\ thyroid\\ gland\\ morphology\\,\\ 2\\-5\\ mci\\ of\\ tc\\ pertechnetate\\ is\\ administered\\ iv\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ 20\\ min\\ later\\ the\\ gland\\ is\\ imaged\\ with\\ a\\ scintillation\\ camera\\ with\\ pinhole\\ collimator\\.\ \(2\)\
\-\ \\&\\#61548\\;\\ anterior\\,\\ left\\ and\\ right\\ anterior\\ oblique\\ images\\ are\\ acquired\\.\ \(0\)\
\-\ graves\\ disease\ \(1\)\
\-\ clinical\\ scenario\ \(5\)\
\-\ \\&\\#61548\\;\\ 35\\ yr\\ old\\ female\\ with\\ clinical\\ and\\ biochemical\\ thyrotoxicosis\\.\\ \\ symptoms\\ of\\ tachycardia\\,\\ weight\\ loss\\,\\ nervousness\\,\\ heat\\ intolerance\\ and\\ possible\\ exophthalmos\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ positive\\ family\\ history\\ of\\ thyroid\\ disease\\.\ \(0\)\
\-\ \\&\\#61548\\;\\ physical\\ exam\\ shows\\ a\\ moderately\\ enlarged\\,\\ nontender\\ thyroid\\ gland\\.\ \(0\)\
\-\ this\\ patient\\ received\\ i131\\ ablation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 61548\\:\\ 0\\.7997391315955243\ \(0\)\
\-\ 8211\\:\\ 0\\.2280014126446804\ \(0\)\
\-\ i131\\:\\ 0\\.18677730093463013\ \(0\)\
\-\ thyroid\\:\\ 0\\.17317239928856515\ \(0\)\
\-\ gland\\:\\ 0\\.15662753486010536\ \(0\)\
\-\ counts\\:\\ 0\\.10296040255843057\ \(0\)\
\-\ dose\\:\\ 0\\.10288928607842866\ \(0\)\
\-\ pertechnetate\\:\\ 0\\.10202550237057317\ \(0\)\
\-\ decay\\:\\ 0\\.08140483916732198\ \(0\)\
\-\ principal\\:\\ 0\\.07924987864280951\ \(0\)\
\-\ kev\\:\\ 0\\.07924987864280951\ \(0\)\
\-\ standard\\:\\ 0\\.07668672416436949\ \(0\)\
\-\ photon\\:\\ 0\\.07357345621321695\ \(0\)\
\-\ raiu\\:\\ 0\\.06586204105586962\ \(0\)\
\-\ uptake\\:\\ 0\\.06353992062189225\ \(0\)\
\-\ energy\\:\\ 0\\.0629638459426945\ \(0\)\
\-\ ablation\\:\\ 0\\.06018561862627708\ \(0\)\
\-\ administered\\:\\ 0\\.0570131617378872\ \(0\)\
\-\ produced\\:\\ 0\\.05609272431608917\ \(0\)\
\-\ moderately\\:\\ 0\\.05557982767918768\ \(0\)\
\-\ in\\:\\ 0\\.05481708163878387\ \(0\)\
\-\ is\\:\\ 0\\.052802412020293184\ \(0\)\
\-\ determined\\:\\ 0\\.052474203468929746\ \(0\)\
\-\ economical\\:\\ 0\\.04404937898039596\ \(0\)\
\-\ peroxidase\\:\\ 0\\.042091533241869705\ \(0\)\
\-\ reactor\\:\\ 0\\.042091533241869705\ \(0\)\
\-\ isomeric\\:\\ 0\\.042091533241869705\ \(0\)\
\-\ phantom\\:\\ 0\\.042091533241869705\ \(0\)\
\-\ equation\\:\\ 0\\.042091533241869705\ \(0\)\
\-\ determin\\:\\ 0\\.042091533241869705\ \(0\)\
\-\ radiotracers\\:\\ 0\\.04070241958366099\ \(0\)\
\-\ 6hr\\:\\ 0\\.04070241958366099\ \(0\)\
\-\ generator\\:\\ 0\\.04070241958366099\ \(0\)\
\-\ counting\\:\\ 0\\.04070241958366099\ \(0\)\
\-\ collimator\\:\\ 0\\.04070241958366099\ \(0\)\
\-\ and\\:\\ 0\\.039841888991630194\ \(0\)\
\-\ later\\:\\ 0\\.039424174942281016\ \(0\)\
\-\ 24\\:\\ 0\\.03905623392791162\ \(0\)\
\-\ storm\\:\\ 0\\.03874457384513474\ \(0\)\
\-\ preference\\:\\ 0\\.03874457384513474\ \(0\)\
\-\ concentrate\\:\\ 0\\.03874457384513474\ \(0\)\
\-\ scintillation\\:\\ 0\\.03874457384513474\ \(0\)\
\-\ enlarged\\:\\ 0\\.037554672149382316\ \(0\)\
\-\ dosage\\:\\ 0\\.03735546018692603\ \(0\)\
\-\ 364\\:\\ 0\\.03735546018692603\ \(0\)\
\-\ biochemical\\:\\ 0\\.03735546018692603\ \(0\)\
\-\ probe\\:\\ 0\\.03678672810660848\ \(0\)\
\-\ uci\\:\\ 0\\.03627797992466978\ \(0\)\
\-\ 8220\\:\\ 0\\.03627797992466978\ \(0\)\
\-\ 8221\\:\\ 0\\.03627797992466978\ \(0\)\
\-\ pinhole\\:\\ 0\\.03627797992466978\ \(0\)\
\-\ nervousness\\:\\ 0\\.03627797992466978\ \(0\)\
\-\ eval\\:\\ 0\\.03581776121377077\ \(0\)\
\-\ camera\\:\\ 0\\.03581776121377077\ \(0\)\
\-\ determination\\:\\ 0\\.03501111689044731\ \(0\)\
\-\ clinical\\:\\ 0\\.034912602142001946\ \(0\)\
\-\ scenario\\:\\ 0\\.0346532760440451\ \(0\)\
\-\ exophthalmos\\:\\ 0\\.0346532760440451\ \(0\)\
\-\ thyrotoxicosis\\:\\ 0\\.03432013418614352\ \(0\)\
\-\ safe\\:\\ 0\\.034008500790191055\ \(0\)\
\-\ neck\\:\\ 0\\.03369925816105069\ \(0\)\
\-\ hrs\\:\\ 0\\.03317869746936191\ \(0\)\
\-\ concentration\\:\\ 0\\.03293102052793481\ \(0\)\
\-\ identical\\:\\ 0\\.03269543030551884\ \(0\)\
\-\ crystal\\:\\ 0\\.0324708018170358\ \(0\)\
\-\ of\\:\\ 0\\.03234181997066293\ \(0\)\
\-\ shows\\:\\ 0\\.032332276903544586\ \(0\)\
\-\ min\\:\\ 0\\.03185354026567857\ \(0\)\
\-\ varies\\:\\ 0\\.03166415749371233\ \(0\)\
\-\ mci\\:\\ 0\\.03148192297134725\ \(0\)\
\-\ trapping\\:\\ 0\\.03130631664731013\ \(0\)\
\-\ yr\\:\\ 0\\.03130631664731013\ \(0\)\
\-\ background\\:\\ 0\\.03097317478940855\ \(0\)\
\-\ obtain\\:\\ 0\\.03081484448281187\ \(0\)\
\-\ anterior\\:\\ 0\\.0307582878487994\ \(0\)\
\-\ divided\\:\\ 0\\.030661541393456088\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.03051295607850954\ \(0\)\
\-\ heat\\:\\ 0\\.03051295607850954\ \(0\)\
\-\ graves\\:\\ 0\\.030368806815068126\ \(0\)\
\-\ intolerance\\:\\ 0\\.030368806815068126\ \(0\)\
\-\ treating\\:\\ 0\\.030228836385053887\ \(0\)\
\-\ 140\\:\\ 0\\.030228836385053887\ \(0\)\
\-\ imaged\\:\\ 0\\.029584061131199844\ \(0\)\
\-\ morphology\\:\\ 0\\.02934847090878387\ \(0\)\
\-\ transition\\:\\ 0\\.028805355025009163\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.028703695654929827\ \(0\)\
\-\ usual\\:\\ 0\\.028604132504429204\ \(0\)\
\-\ estimated\\:\\ 0\\.028604132504429204\ \(0\)\
\-\ correction\\:\\ 0\\.028317198096977365\ \(0\)\
\-\ po\\:\\ 0\\.0282252211879802\ \(0\)\
\-\ effective\\:\\ 0\\.02813496357461228\ \(0\)\
\-\ tachycardia\\:\\ 0\\.02813496357461228\ \(0\)\
\-\ t4\\:\\ 0\\.027626215392673584\ \(0\)\
\-\ drugs\\:\\ 0\\.0275464013156079\ \(0\)\
\-\ thigh\\:\\ 0\\.02709338415969587\ \(0\)\
\-\ functional\\:\\ 0\\.027021847418333158\ \(0\)\
\-\ tsh\\:\\ 0\\.02661355008645154\ \(0\)\
\-\ accumulation\\:\\ 0\\.02661355008645154\ \(0\)\
\-\ tc\\:\\ 0\\.02661355008645154\ \(0\)\
\-\ acquired\\:\\ 0\\.02654873513041734\ \(0\)\
\-\ depending\\:\\ 0\\.026237101734464873\ \(0\)\
\-\ nuclear\\:\\ 0\\.02605934024782839\ \(0\)\
\-\ nontender\\:\\ 0\\.025944367156076915\ \(0\)\
\-\ lab\\:\\ 0\\.024878261791245228\ \(0\)\
\-\ versus\\:\\ 0\\.024360411548696698\ \(0\)\
\-\ homogeneous\\:\\ 0\\.024319663275452232\ \(0\)\
\-\ medicine\\:\\ 0\\.024279255995938612\ \(0\)\
\-\ physician\\:\\ 0\\.02416002421651694\ \(0\)\
\-\ radiotracer\\:\\ 0\\.024043665773522644\ \(0\)\
\-\ received\\:\\ 0\\.023967622599986152\ \(0\)\
\-\ oblique\\:\\ 0\\.02385575717092329\ \(0\)\
\-\ hr\\:\\ 0\\.023674888021598187\ \(0\)\
\-\ by\\:\\ 0\\.023393839446537515\ \(0\)\
\-\ disease\\:\\ 0\\.02312426184675102\ \(0\)\
\-\ using\\:\\ 0\\.02265455211531393\ \(0\)\
\-\ 100\\:\\ 0\\.022597407759341943\ \(0\)\
\-\ compared\\:\\ 0\\.02226805455736147\ \(0\)\
\-\ 35\\:\\ 0\\.022085820034996383\ \(0\)\
\-\ procedure\\:\\ 0\\.021959738675605963\ \(0\)\
\-\ family\\:\\ 0\\.021669933209666762\ \(0\)\
\-\ with\\:\\ 0\\.021574096133592516\ \(0\)\
\-\ free\\:\\ 0\\.02144104478114234\ \(0\)\
\-\ typical\\:\\ 0\\.021287043154103787\ \(0\)\
\-\ made\\:\\ 0\\.021243929995156112\ \(0\)\
\-\ single\\:\\ 0\\.021179973540630746\ \(0\)\
\-\ complications\\:\\ 0\\.021095995046123906\ \(0\)\
\-\ rare\\:\\ 0\\.020793475982678285\ \(0\)\
\-\ to\\:\\ 0\\.02065808466447815\ \(0\)\
\-\ used\\:\\ 0\\.020620663203251184\ \(0\)\
\-\ activity\\:\\ 0\\.020222572262241497\ \(0\)\
\-\ based\\:\\ 0\\.019952367972433004\ \(0\)\
\-\ iv\\:\\ 0\\.01968093483583405\ \(0\)\
\-\ status\\:\\ 0\\.019222127802104486\ \(0\)\
\-\ weight\\:\\ 0\\.01920802956807834\ \(0\)\
\-\ elevated\\:\\ 0\\.018777336074691158\ \(0\)\
\-\ possible\\:\\ 0\\.01866281746472492\ \(0\)\
\-\ size\\:\\ 0\\.01865025922169372\ \(0\)\
\-\ radiation\\:\\ 0\\.018253160909266777\ \(0\)\
\-\ positive\\:\\ 0\\.018150298379257034\ \(0\)\
\-\ 20\\:\\ 0\\.017769893745423704\ \(0\)\
\-\ will\\:\\ 0\\.01772826726587237\ \(0\)\
\-\ medical\\:\\ 0\\.017505523125402992\ \(0\)\
\-\ days\\:\\ 0\\.017436751887522126\ \(0\)\
\-\ decreased\\:\\ 0\\.01706152304349086\ \(0\)\
\-\ demonstrated\\:\\ 0\\.016928003705583432\ \(0\)\
\-\ evaluation\\:\\ 0\\.016798077255735087\ \(0\)\
\-\ loss\\:\\ 0\\.01678101489973515\ \(0\)\
\-\ on\\:\\ 0\\.016637720483316368\ \(0\)\
\-\ following\\:\\ 0\\.0165239792981745\ \(0\)\
\-\ the\\:\\ 0\\.016488275269436886\ \(0\)\
\-\ focal\\:\\ 0\\.016475772824005988\ \(0\)\
\-\ include\\:\\ 0\\.016388625160790756\ \(0\)\
\-\ 10\\:\\ 0\\.016106524833806465\ \(0\)\
\-\ symptoms\\:\\ 0\\.015070696699281235\ \(0\)\
\-\ physical\\:\\ 0\\.01493516765652663\ \(0\)\
\-\ increased\\:\\ 0\\.014894663533986495\ \(0\)\
\-\ can\\:\\ 0\\.01445439140928444\ \(0\)\
\-\ exam\\:\\ 0\\.01386582915028006\ \(0\)\
\-\ findings\\:\\ 0\\.013594231322207233\ \(0\)\
\-\ surgical\\:\\ 0\\.013387442539913318\ \(0\)\
\-\ female\\:\\ 0\\.013291409318706699\ \(0\)\
\-\ treatment\\:\\ 0\\.01312082559794945\ \(0\)\
\-\ images\\:\\ 0\\.012741086112092063\ \(0\)\
\-\ normal\\:\\ 0\\.011246164963898882\ \(0\)\
\-\ be\\:\\ 0\\.011173633237652485\ \(0\)\
\-\ an\\:\\ 0\\.01053285906817906\ \(0\)\
\-\ history\\:\\ 0\\.010523528356630738\ \(0\)\
\-\ are\\:\\ 0\\.01045182026348911\ \(0\)\
\-\ or\\:\\ 0\\.009582181701204158\ \(0\)\
\-\ this\\:\\ 0\\.009464727582751626\ \(0\)\
\-\ left\\:\\ 0\\.009395971468664624\ \(0\)\
\-\ right\\:\\ 0\\.00913208483506019\ \(0\)\
\-\ patient\\:\\ 0\\.008958787567058828\ \(0\)\
\-\ no\\:\\ 0\\.00895710247134334\ \(0\)\
\-\ for\\:\\ 0\\.008348474819146676\ \(0\)\
\-\ old\\:\\ 0\\.008152013600107975\ \(0\)\
